A box only slightly larger than a shoebox is on its way to the International Space Station, and inside it are some of the smallest patients medicine has ever sent into orbit. Researchers from the Icahn School of Medicine at Mount Sinai in New York, working with NASA and the space company Space Tango, have launched miniature human hearts and brains on the commercial resupply mission CRS-35. The flight lifted off from Cape Canaveral Space Force Station in Florida on Tuesday morning, and the cargo is due to reach the station on Thursday.
It is the first time that lab-grown mini organs of this kind are being flown to space. The idea behind the project is simple to state and hard to test on the ground: life in orbit seems to speed up the aging of the human body, and scientists want to watch that process happen in real tissue, in real time, without putting an astronaut at risk.
Spaceflight is tough on people. Without gravity pulling on them, muscles and bones lose strength, fluids shift towards the head, and the heart no longer has to work as hard to push blood upwards. On top of that comes radiation that the atmosphere usually filters out. Kevin Costa, an associate professor of surgery at Mount Sinai, has put a striking number on the combined effect: in his words, six months in space is roughly equivalent to ten to twenty years of aging on Earth.
That is a problem for anyone planning long missions. It is also, as the team points out, an opportunity. If a few weeks on the station can compress years of wear and tear, then orbit becomes a kind of fast-forward button for studying how organs decline, and what might slow that decline down.
The mission carries up to 16 miniature hearts. They are not full organs but small, lab-grown models of human heart tissue. David Sachs, an assistant professor of surgery at Mount Sinai and one of the leaders of the work, wants to see how they respond to electrical signals and how their behaviour changes in near-weightlessness. The group has some groundwork to build on: in 2023, the Cardiovascular Research Institute at Mount Sinai sent individual heart cells to the station and showed that they could survive there.
Alongside the hearts travel miniature brains, which the researchers call miBrains. Each is roughly the size of a peppercorn. Some are modelled on healthy brain tissue, others on tissue affected by disease, which lets the team compare how the two react to the stresses of space. Joel Blanchard, an associate professor of stem cell biology, regenerative medicine and neuroscience at Mount Sinai, says the results will feed directly back into his laboratory’s work on Parkinson’s and Alzheimer’s disease.
All of this needs a home that keeps the tissue alive without a scientist standing next to it. That is the job of the CubeLab, a compact, fully automated laboratory built by Space Tango. According to the company’s chief technology officer, Gentry Barnett, the unit mimics the conditions the cells would normally experience inside a human body, supplying them with what they need while the station circles the planet.
Why tiny organs could matter for patients on Earth
It would be easy to file this under space exploration and move on, but the researchers insist that the main beneficiaries may never leave the ground. Sachs describes the project as a model of accelerated aging that is useful for studying people on Earth, not only astronauts.
One reason is that weightlessness reproduces something that is very hard to simulate in a hospital or a lab: what happens to the body when it hardly moves at all. Long periods of bed rest after an operation, a serious illness or simply a very sedentary lifestyle all leave their mark on the heart and other organs. Orbit offers an extreme, controlled version of that situation, and watching how heart tissue adapts or weakens there could help doctors understand what goes on in patients who are confined to bed for weeks.
The brain models add a second layer. Neurodegenerative diseases such as Parkinson’s and Alzheimer’s usually develop over decades, which makes them painfully slow to study. If spaceflight really does speed up aging processes in brain tissue, researchers may be able to observe changes in weeks that would take years in a normal lab dish. That could make it quicker to spot early warning signs or test whether a potential drug protects cells under stress.
There is also a practical argument for using mini organs rather than people or animals. They are cheap compared with the cost of sending a human crew member, they fit into a small box, and they do not take up much of the very limited room on board the station. The researchers acknowledge that a clump of tissue the size of a peppercorn is not the same as a complete human brain, but they see these models as good stand-ins for questions that would otherwise be almost impossible to answer.
NASA sees the experiment as a starting point. Lisa Carnell, who directs the agency’s biological and physical sciences division, says this kind of work prepares the ground for research beyond low Earth orbit, including missions to the Moon and further out. She notes that Apollo astronauts flew to the Moon more than half a century ago, but the tools available to measure what happens inside the body have advanced enormously since then.
The timing is no accident. NASA plans to put astronauts back on the lunar surface in 2028 and to build a permanent base there in the following decade. NASA and SpaceX have also talked about sending humans to Mars. Crews on those journeys will spend far longer away from Earth than anyone on a typical station rotation, and they will face more radiation once they leave the protection of Earth’s magnetic field. Knowing in advance how the heart and brain cope is not a luxury for such missions. It is a basic safety question.
Carnell sums up the mood among the scientists by saying that taking biology to space is about making leaps rather than small, incremental steps, because researchers can see changes up there that they simply cannot observe on the ground.
For now, the tiny hearts and brains still have to complete their journey. Once the CRS-35 cargo is docked and unpacked, the CubeLab will start its automated routine, and the data will begin to flow back to the teams in New York. It may take months before the first findings are analysed and published. But the experiment already marks a shift in how medicine thinks about space: not just as a destination that people must be protected from, but as a laboratory that might help explain why our bodies grow old, and how that process could one day be slowed for everyone, whether they ever fly or not.
